The ISSUP activities funded by the U.S. Department of State are temporarily suspended.
This website will remain live, but ISSUP is not currently monitoring or updating it. No new membership applications will be accepted or reviewed, no posts or comments will be possible, and members cannot login.
This information will be updated with any change in circumstances. Thank you for your understanding.

Jose Luis Vazquez Martinez

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder

Jose Luis Vazquez Martinez - 16 July 2021

GIF

Source:

Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128

 

Key Points

Question  Is high-dose (>12 mg) buprenorphine induction safe and well tolerated in patients with untreated opioid use disorder who present to the emergency department?

 

Findings  In this case series of 579 cases, 54 clinicians followed a high-dose buprenorphine (monoproduct) protocol. There were no documented episodes of respiratory depression or excessive sedation, and precipitated withdrawal was rare (0.8% of cases) and was not associated with dosing.

 

Meaning  These findings suggest that high-dose buprenorphine induction, adopted by multiple clinicians in a single-site, urban emergency department, was safe and well tolerated in patients with untreated opioid use disorder.